首页|Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm

Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
  • 维普
Background and Aims: Perivascular epithelioid cell neo-plasms (PEComas) are a rare type of mesenchymal neo-plasm and their preoperative diagnosis is challenging. In this study, we summarized the experience from a single medical center to study the examinations, clinical presen-tations, and pathological and histological characteristics of PEComas in the liver in order to optimize overall un-derstanding of the diagnosis and treatment of these neo-plasms. Methods: We conducted a retrospective analysis to investigate the clinical and pathological characteristics as well as imaging presentations of 75 patients diagnosed with hepatic PEComa in The First Affiliated Hospital of Zhe-jiang University between April 2010 and April 2020. Re-sults: Among the 75 patients, 52 were women, and the median age was 48 years. Most patients had no specific symptoms, and two were admitted to the hospital for a second time owing to relapse. All patients underwent surgi-cal resection. Histologically, 38 patients had classical angio-myolipoma (AML) and 37 had epithelioid AML. The PECo-mas were accompanied by positive immunohistochemical expression of HMB45, Melan-A, and smooth muscle actin. Follow-up data were obtained from 47 of the total 75 pa-tients, through October 2020. Two patients had metastasis after surgery. Conclusions: AML is the most common type of hepatic PEComa. There are no specific symptoms of he-patic PEComa, and serological examinations and imaging modalities for accurate preoperative diagnosis are lacking. Epithelioid AML should be considered a tumor of uncertain malignant potential; however, the prognosis of PEComa af-ter resection is promising.

LiverPerivascular epithelioid cell neoplasmsDiagnosisTreat-ment

Junjun Jia、Jia Luo、Cheng-Gen Pan、Guomei Ge、Meibao Feng、Bei Zou、Li Liu、Shusen Zheng、Jun Yu

展开 >

Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China

Key Laboratory of Organ Transplantation,Research Center for Diagnosis and Treatment of Hepatobiliary Diseases,Hangzhou,Zhejiang,China

Department of Pathology,The First Affiliated Hospi-tal,College of Medicine,Hangzhou,Zhejiang,China

Department of Library,The First Affiliated Hospital,Zhejiang Univer-sity School of Medicine,Hangzhou,Zhejiang,China

展开 >

Zhejiang Natural Science Foun-dationZhejiang Health Technology Project

LQ20H0300052020KY126/2019RC153

2022

10.14218/JCTH.2020.00170

临床与转化肝病杂志(英文版)

临床与转化肝病杂志(英文版)

ISSN：
年,卷(期)：2022.10(1)
  • 6
  • 23